CLOs on the Move

Acucela

www.acucela.com

 
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.acucela.com
  • 1301 2nd Ave # 1900
    Seattle, WA USA 98101
  • Phone: 206.805.8300

Executives

Name Title Contact Details

Similar Companies

Portage Path Behavorial Health

Portage Path Behavorial Health is a Akron, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Honors Holdings

Honors Holdings, LLC is a leading franchisee of Orangetheory Fitness studios globally.

OptiScan Biomedical Corp

OptiScan Biomedical Corp is a Hayward, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wave Life Sciences

WAVE Life Sciences is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering exceptional treatment options for patients. Given the unique versatility of its chemistry platform, WAVE`s pipeline will span multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded RNAi.

NexGen Healthcare

NexGen Healthcare is a Santa Clara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.